This variant lies on Chromosome 12 and affects the gene KRAS (KRAS proto-oncogene, GTPase). Based on this context, is the mutation pathogenic or benign? If pathogenic, what disease does it cause?
Pathogenic; Cardiofaciocutaneous syndrome 2